Standard dosing algorithms could be responsible for the higher rates of thyrotoxicosis among older women vs men prescribed levoythroxine.

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

Now that injectable weight loss drugs are slowly making their way to India, many patients have been asking me if microdosing, or taking a limited dose, is an option to help them get off the weight ...

Tracye Craven, 65, was at her highest weight after losing her job and her father — but a wake-up call at the doctor led her to prioritize her health and look past her 'real good excuses' When ...

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly dosing NPM-139 is a miniature, subdermal implant in ...

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly dosing NPM-139 is a miniature, subdermal implant in development ...

These results reinforce the company’s commitment to addressing chronic weight management and other chronic diseases by leveraging its proprietary NanoPortal™ implant technology which is ...

Single dose of Vivani’s NPM-139 semaglutide implant led to nearly 20% weight loss in rats, suggesting once- or twice-yearly dosing. NPM-139 showed steady semaglutide release with potential for ...

NPM-139 treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly dosing. Also Read: EXCLUSIVE: Vivani Medical To Spin Off ...